Intermediates APIs Generic drugs Big health food
Intermediates
Intermediates APIs Generic drugs Big health food
Ibrutinib N-1
category：Intermediates
release date：2021-10-03

3-(4-phenoxyphenyl)-1-(3-piperidyl)pyrazolo[3,4-d]pyrimidin-4-amine 


SPECIFICATION: In-House 

DOCUMENTATION: Technical package

CAS NO. : 1022150-12-4

INDICATION: Ibrutinib N-1 
Next：Enpagliflozin intermediate
Back
  • Related Products
Duloxetine intermediate
Duloxetine intermediate
Duloxetine intermediate
Duloxetine intermediate
Pioglitazone intermediate
Pioglitazone intermediate
Febuxostat intermediate
Febuxostat intermediate
Mirabegron intermediate
Mirabegron intermediate
Febuxostat intermediate
Febuxostat intermediate
Febuxostat intermediate
Febuxostat intermediate
Cobisistat intermediate
Cobisistat intermediate
Cobisistat intermediate
Cobisistat intermediate
Enpagliflozin intermediate
Enpagliflozin intermediate
Address：No.15 Shuangfeng Rd., Fotang, Yiwu, Zhejiang 322002, China
Copyright © 2021 Zhejiang Huayi Pharmaceutical Co., Ltd. All rights reserved. ICPNo. 浙05012164
About Us
Company Profile
Chairman's speech
Company Memorabilia
Leadership care
Honor
Cultural vision
Contact Us
News
Company News
Industry News
Investor Relations
Company Overview
Company Announcement
Products and services
Intermediates
APIs
Generic drugs
Big health food
R & D innovation
Scientific research results
Quality and Safety
Innovation dynamics
HR
Training and development
Incentive guarantee
Recruitment
Copyright © 2021 Zhejiang Huayi Pharmaceutical Co., Ltd. ICPNo. 浙05012164by:e7cn.net
关闭
客服中心
工作时间

周一至周日

8:00 - 18:00

请直接QQ联系!
展开客服